Systemic redox imbalance in severe COVID-19 patients.

Abstract

The aim of this study was to evaluate the systemic redox state and inflammatory markers in intensive care unit (ICU) or non‐ICU severe COVID‐19 patients during the hospitalization period. Blood samples were collected at hospital admission (T1) (Controls and COVID‐19 patients), 5–7 days after admission (T2: 5–7 days after hospital admission), and at the discharge time from the hospital (T3: 0–72 h before leaving hospital or death) to analyze systemic oxidative stress markers and inflammatory variables. The reactive oxygen species (ROS) production and mitochondrial membrane potential (MMP) were analyzed in peripheral granulocytes and monocytes. THP‐1 human monocytic cell line was incubated with plasma from non‐ICU and ICU COVID‐19 patients and cell viability and apoptosis rate were analyzed. Higher total antioxidant capacity, protein oxidation, lipid peroxidation, and IL‐6 at hospital admission were identified in both non‐ICU and ICU COVID‐19 patients. ICU COVID‐19 patients presented increased C‐reactive protein, ROS levels, and protein oxidation over hospitalization period compared to non‐ICU patients, despite increased antioxidant status. Granulocytes and monocytes of non‐ICU and ICU COVID‐19 patients presented lower MMP and higher ROS production compared to the healthy controls, with the highest values found in ICU COVID‐19 group. Finally, the incubation of THP‐1 cells with plasma acquired from ICU COVID‐19 patients at T3 hospitalization period decreased cell viability and apoptosis rate. In conclusion, disturbance in redox state is a hallmark of severe COVID‐19 and is associated with cell damage and death.